VEGFA and cancer: VEGF is a key regulatory protein involved in promoting angiogenesis and CH has been reported to inhibit the expression and simultaneous inactivation of VEGF, thereby limiting the augmentation of new blood vessels leading to restricted blood supply to cancer cells [39].